Indolent Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-12-05
Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia [Phase 2]
Phase 2 study evaluating safety and efficacy of pacritinib in relapsed or refractory Waldenström macroglobulinemia; the trial is currently r…